The AVANZA Advisory Board  - Scientific and Regulatory

 

Edward Jackson Cone, Ph.D.

 

Edward J. Cone received his B.S. in chemistry from Mobile College in 1967 and his Ph. D. in organic chemistry in 1971 from the University of Alabama. From 1971 to 1972 he held a post-doctoral appointment in the Department of Chemistry, University of Kentucky. His work at the University of Kentucky was in the area of tobacco chemistry. In the summer of 1972, he joined the staff of the Addiction Research Center, National Institute on Drug Abuse. In 1984, the center was moved to Baltimore, MD, where he served as Chief of the Chemistry and Drug Metabolism Section and Acting Branch Chief of Clinical Pharmacology until 1998. From 1977 to 1985 he served as a member of the adjunct faculty in the Division of Pharmaceutics and Pharmaceutical Analysis, School of Pharmacy, University of Kentucky. He has also been appointed as Adjunct Professor of Psychiatry at Johns Hopkins School of Medicine. Dr. Cone serves on the editorial board of the Journal of Analytical Toxicology and is a reviewer for numerous chemical and pharmacology journals. Dr. Cone served as Vice-Chairman of the Institutional Reviews Board for the Intramural Research Program, NIDA, in Baltimore, MD from 1996-98. His research interests are in drug delivery systems, kinetics and disposition of drugs, and in the relationship of drug testing results to drug-induced effects. Dr. Cone’s research on the kinetics and dynamics of drug exposure effects of environmental inhalation of drugs, and the use of alternative biological media for drug detection has been recognized world-wide. Dr. Cone’s research has resulted in the publication of over 250 scientific articles on the detection and analysis of drugs in biological media. Dr. Cone has received a number of awards including the Alan Curry Award in 2006, from The International Association of Forensic Toxicologists. Presently, Dr. Cone is serving as a consultant to private industry and various government agencies on matters relation to the standardization of drug testing methodologies and drug surveillance systems.

 

Return to the Advisory Board - Scientific and Regulatory members